BD Onclarity™ HPV assay adheres to new guidelines by identifying more individual types of HPV than any other test on the market FRANKLIN LAKES, N.J., Jan. 13, 2025 /PRNewswire/ -- BD (Becton, ...

Early detection and modern treatments make cervical cancer one of the most preventable and treatable cancers. Newport Women’s ...

The American Society for Colposcopy and Cervical Pathology (ASCCP) has issued new guidelines reflecting the importance of extended genotyping in HPV testing to support an enhanced standard of patient ...

INDIANAPOLIS, March 11, 2024 /PRNewswire/ -- Roche Diagnostics today announced the release of new guidelines from ASCCP and other members of the Enduring Guidelines for Cervical Cancer Screening and ...

Becton Dickinson (BDX) announced that the BD Onclarity HPV Assay has officially been added to the American Society for Colposcopy and Cervical Pathology, or ASCCP, enduring risk-based management ...

Roche’s CINtec PLUS Cytology is the only FDA-approved and CE-marked dual-stain test to triage human papillomavirus (HPV)-positive cervical cancer screening test results Dual-stain biomarkers aid in ...

To permanently access this Guide for free, fill out the short form below. The American Society for Colposcopy and Cervical Pathology (ASCCP) announced new guidelines that includes extended genotyping.

SAN DIEGO, April 29, 2025 /PRNewswire/ -- PHASE Scientific (PHASE) proudly announced a major milestone this week with its inaugural participation and award-winning presentation at the 2025 American ...